AIVITA Biomedical Presents Updates from Ongoing Ovarian Cancer and Glioblastoma Clinical Studies at 2020 AACR Virtual Annual Meeting
IRVINE, Calif. – April 27, 2020 – AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications,…
AIVITA Biomedical Publishes Study Comparing Immune Responses and Associated Survivals Induced by Dendritic and Tumor Cell Vaccines
IRVINE, Calif. – April 23, 2020 – AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications,…
AIVITA Biomedical Provides Update of Ongoing Phase 2 Glioblastoma Trial from Year-End Survival Analysis
IRVINE, Calif. – April 8, 2020 – AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications,…
AIVITA Biomedical Raises $12.5 Million in Series B-2 Financing Round and Announces New Board of Directors Appointee
IRVINE, Calif. – February 25, 2020 – AIVITA Biomedical, Inc., a biotechnology company (the “Company”) specializing in innovative stem…
AIVITA Biomedical to Present at 2020 BIO CEO & Investor Conference
IRVINE, Calif. – February 10, 2020 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical Completes Patient Recruitment in Phase 2 GBM Trial
IRVINE, Calif. – February 4, 2020 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical to Present at Biotech Showcase 2020
IRVINE, Calif. – January 14, 2020 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
ROOT OF SKIN™ Skincare Products Sell Out on Every QVC Japan Show in 2019
IRVINE, Calif. – January 8, 2020 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
AIVITA Biomedical Announces New Positive Phase 2 Glioblastoma Data at SITC Annual Meeting Podium Presentation
IRVINE, Calif. – November 12, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…
Brain Cancer Patient Survival, Immune and Tumor Data from AIVITA Biomedical’s Phase 2 Clinical Trial to be Presented at SITC Annual Meeting
IRVINE, Calif. – November 8, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…